27th Annual Meeting of the European Charcot Foundation, 21 - 23 November 2019, Baveno
Dr. Martina Absinta
Johns Hopkins University (JHU), Baltimore

Dr. Martina Absinta, MD, PhD is an Assistant Professor in Neurology at Johns Hopkins School of Medicine, Baltimore, US. She earned her medical degree, residency in neurology, and international PhD in molecular medicine–experimental neurology at Vita-Salute University-San Raffaele Hospital, Milan, Italy. From 2012 to 2019 she joined Dr. Daniel S. Reich’s lab (Neurological Disorders and Stroke [NINDS], National Institutes of Health [NIH], Bethesda, US) first as Visiting Postdoctoral Fellow, then as a Research Fellow. Her research interests include ultra-high-field 7T MRI–neuropathology correlations in multiple sclerosis, related identification of novel imaging biomarkers of chronic inflammation (with special focus on microglia-mediated and leptomeningeal inflammation), and strategies to limit it.

COI form

Dr. Francesca Aloisi
Istituto Superore di Sanita, Rome

Francesca Aloisi is Head of Research at Istituto Superiore di Sanità in Rome and leads the Unit ‘Demyelinating and Inflammatory Diseases of the Nervous System’ in the Department of Neuroscience. She is a biologist with past research interests in neuropharmachology, neurochemistry, biology of glial cells and neuro-immune interactions. In the last 15 years, her research interests have focussed on multiple sclerosis pathogenesis, particularly on the involvement of and interaction between B cells, Epstein-Barr virus and the antiviral immune response in sustaining CNS inflammation and tissue damage.


Prof. Amit Bar-Or
University of Pennsylvania

Dr. Bar-Or is the inaugural Melissa and Paul Anderson President’s Distinguished Professor of Neurology at the Perelman School of Medicine, University of Pennsylvania where he Directs the Centre for Neuroinflammation and Experimental Therapeutics (CNET) and serves as Chief of the Division of Multiple Sclerosis and Related Disorders. He is former Professor in the Department of Neurology and Neurosurgery at the Montreal Neurological Institute and Hospital, McGill University, where he also served as the Institute’s Associate Director prior to arriving at Penn.

Dr. Bar-Or’s clinical focus is Multiple Sclerosis (MS) and related disorders in both adults and children for which he is cross-appointed at the Children’s Hospital of Philadelphia (CHOP) and co-directs the age-span program in MS and related disorders with long-standing collaborator and friend Dr. Brenda Banwell ensuring seamless pediatric through adulthood transition of care, education and research. Dr. Bar-Or runs a cellular and molecular Neuroimmunology lab studying principles of immune regulation and immune-neural interaction in the context of injury and repair of the human central nervous system (CNS). He is co-PI of the newly NIH awarded Penn Autoimmunity Center of Excellence (ACE).
Ongoing themes of his lab work and the Penn CNET which he directs, involve elucidation of effector and regulatory mechanisms by which distinct human immune cell subsets (principally T cells, B cells, myeloid cells) interact with one another and with CNS (glial, neuronal) cells, contributing to both ‘Neuroimmune Health’ and to a range of CNS inflammatory diseases across the age-span. Of particular interest are human immune-monitoring studies, studies of immune reconstitution, design and implementation of mechanism-of-action and biological proof-of-principle studies of emerging therapies, and development of clinically meaningful biomarkers as part of advancing precision medicine in autoimmune and CNS-inflammatory diseases.
Dr. Bar-Or is passionate about education and mentoring, having trained over 80 students at all levels, with emphasis on clinician-scientist trainees, all of whom have continued active and successful careers at the clinical-research interface. He has published over 250 peer-reviewed publications, led multiple national and international collaborative research initiatives and is considered a highly sought after speaker. He is past President of the Canadian Network of MS Clinics (CNMSC) and past member of the Board of Directors of the Federation of Clinical Immunology Societies (FOCIS). He currently serves on the FOCIS Education Committee, is a member of the Board of Directors of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) and on the Steering Committee of the NIH Immune Tolerance Network (ITN). Dr. Bar-Or is also a long-standing member of the Scientific Advisory Board of the International Society of Neuroimmunology (ISNI) and currently serves as ISNI President.

Prof. Luca Battistini
European Centre for Brain Research, Santa Lucia Foundation, Rome

Luca Battistini was born in Genova, Italy, in 1964. After obtaining his Medical Degree in 1989, he completed the Residency in Neurology in 1994. He worked as a postdoctoral fellow at the Albert Einstein College of Medicine and was then appointed as Research Associate at the Biochemistry Department, E.K. Shriver Center where he directed the Neuroimmunology Lab and in 1996 as Instructor of Neurology at Harvard Medical School. After returning to Italy he established the Neuroimmunology Lab at the European Centre for Brain Research at the Santa Lucia Foundation in Rome, also setting up a Flow Cytometry Facility with advanced instrumentation. He has obtained significant grants from private national and international Foundations. The National Multiple Sclerosis Society USA (NMSS) and the Italian Foundation for MS (FISM) have sustained Luca Battistini’s research for the past 25 years. In 2002, FISM assigned him the Rita Levi Montalcini prize for “Best Young Researcher” for his studies on the role of T lymphocytes in multiple sclerosis. Since 2016 he is member of the Scientific Board of the International Society for NeuroImmunology (ISNI). He has published over 130 papers on peer reviewed journals (H index 51), and has served as a reviewer for several funding agencies and international journals. He was appointed Vice-Scientific Director of the Fondazione Santa Lucia IRCCS on January 2018.

Prof. Jeffrey Bennett
University of Colorado Anschutz Medical Campus

Dr. Jeffrey L. Bennett is the Gertrude Gilden Professor for Neurodegenerative Disease Research in the Departments of Neurology and Ophthalmology at the University of Colorado School of Medicine. He is also a faculty member of Department of Immunology, Program in Neuroscience, and the Rocky Mountain MS Center at Anschutz Medical Campus.

Dr. Bennett received his medical and doctoral degrees at Stanford University and completed his internship and residency in Neurology at the University of Colorado. He subsequently completed a clinical fellowship in neuro-ophthalmology at the University of Pennsylvania and post-doctoral research at the University of Colorado Boulder. Dr. Bennett directs basic, translational, and clinical research programs on neuromyelitis optica spectrum disorder, multiple sclerosis, and optic neuritis and maintains active specialty practices in neuro-ophthalmology and neuro-immunology. He has received the Stephen Reingold Award from the National Multiple Sclerosis Society and the CU Inventor of the Year Award from the University of Colorado.
Dr. Bennett has been a leader in understanding the role of B cells in demyelinating disorders. Using single cell recombinant monoclonal antibody technology, his laboratory has probed the targets of the immune response in NMOSD and MS. His research in NMOSD has elucidated the pathogenicity of AQP4 autoantibodies, identified B cell epitopes on AQP4 protein, and assisted in the development of novel antigen-specific therapies. Dr. Bennett is widely published, is a regular member of scientific review committees for the National Institutes of Health and the National Multiple Sclerosis Society. He performs editorial services for numerous scholarly publications in fields of neuroimmunology and neuro-ophthalmology.

Dr Joakim Bergman
Umea University Hospital

Dr Joakim Bergman is a junior doctor at the University Hospital of Umeå, Sweden. He received his medical degree in 2016 and is currently doing his general rotations before residency. Dr Bergman is a PhD-student at the Department of Clinical Sciences at Umeå University, Sweden. He has been working for prof. Anders Svenningsson at Karolinska University Hospital, Huddinge, Sweden since 2011. The project, which is still ongoing, is a pharmaceutical trial of intraventricular injection of rituximab in patients with progressive MS.



Prof. Alexey Boyko
Russian State Medical University and MS Center, Moscow

Alexey Boyko gained his MD and PhD from the Russian State Medical University, Moscow and has been Professor of the Department of Neurology and Neurosurgery at this university since 1997. He was the Chief Neurologist of the Department of Health Care of the Government of Moscow in 2001-2015, Director of the Moscow Multiple Sclerosis Center in 2004-2014 and Director of the MS Clinical and Research Center of Neuroclinic (Ysupov Hospital) since 2015. He was elected as a Honourable Professor of Kazan and Yaroslavl State Medical Universities. Professor Boyko has been a member of the "Oslo International Think-tank on Multiple Sclerosis Epidemiology, Analytical Approaches to Study of the Aetiology" at the Center for Advanced Studies of the Norwegian Academy of Science and Letters in 1994-1995, and worked at UBC MS Center in 1998 (Vancouver, Canada). He is also a member of the Presidium of the All-Russian Society of Neurologists, Co-ordinator of the Medical Consulting Boards of Moscow and All-Russian MS Societies, President of RUCTRIMS, member of the ECTRIMS Council. Professor Boyko has published 15 books, 12chapters in books and more than 800 original publications and is a co-editor of three medical journals. The main interest is epidemiology and genetic of MS, neuroimmunology, clinical trials in MS. He is a member of several Advisory Boards of ongoing and finished clinical trials, a member of Editorial Boards of several international medical journals.

Prof. Massimiliano Calabrese
University of Verona

Massimiliano Calabrese is Professor of Neurology at Department of Neurosciences, Biomedicine and Movement at University of Verona. He leads the Multiple Sclerosis Center of University of Verona and the International Centre for Advance Research in Multiple Sclerosis (ICARE-MS). Following medical degree and training in neurology he completed a clinical fellowship at the Neuroimmunology Branch of National Institute of Health in Bethesda. He has a special expertise in advanced MRI acquisition and analysis particularly as they relate to understanding the pathogenesis and the evolution of Multiple Sclerosis. Since 2005 his clinical research activity has been focused on neurodegeneration and neuroprotection in Multiple Sclerosis, with the ultimate aim of predicting and of slowing down the accumulation and progression of irreversible disability. His work on grey matter inflammation and neurodegeneration in Multiple Sclerosis has earned more than 90 highly cited publications in international peer reviewed journals and several international awards.

As a lead clinician in the MS service at Multiple Sclerosis Center of University Hospital of Verona, he has a strong commitment to patient care. Prof. Calabrese and his team follow more than 2.000 MS patients. He has contributed to the development of important pathways for new MS medications, and developed international and local MRI protocols for diagnosing MS and monitoring patients on disease modifying drugs. He run specialist MS and diagnostic clinics with multidisciplinary input from therapists and MS specialist nurses. Over the last 15 years, Prof. Calabrese conducted more than 30 international Phase 2 and Phase 3 clinical trials in 12 of which he was the Principal Investigator
He is currently the PI of 6 international Phase 2 and 3 Clinical Trials. He teaches several students on general Neurology, Multiple Sclerosis and Advanced Neuroimaging and he is currently the primary supervisor of 6 PhD students. He regularly gives lectures at national and international conferences and has organized workshops and teaching courses at international conferences.

Prof. William Carroll
Perron Institute Perth, Sir Charles Gairdner Hospital and University of Western Australia

Professor William Carroll is a Consultant Neurologist, President of the World Federation of Neurology, a member of the steering committee of the International Progressive MS Alliance (IPMSA), Board member of the European Charcot Foundation and Patron of the Pan Asian Committee for Research and Treatment of MS (PACTRIMS) having recently stepped down as the Treasurer and foundation Vice President. Professor Carroll is the Chair of the Multiple Sclerosis Research Australia International Research Review Board, has served previously as Chair of the Multiple Sclerosis Research Australia Management Council, President of the Australian and New Zealand Association of Neurologists, President of the XVlll World Congress of Neurology 2005, Chair of the Organising Committee of the XXIV World Congress of Neurology and the Asia Pacific editor of the Multiple Sclerosis Journal. His principal research activity has been in demyelinating disease both in multiple sclerosis and in experimental optic neuropathy, and of the biology of demyelination and remyelination. Professor Carroll was recently made a member of the Order of Australia for his work in neurology and for people with multiple sclerosis.


Prof. Jeffrey Cohen
Cleveland Clinic Lerner College Medicine

Dr. Cohen is Professor of Medicine (Neurology) in the Cleveland Clinic Lerner College of Medicine.He received a BA from Connecticut College in 1976 and MD from the University of Chicago School of Medicine in 1980.He completed a Neurology Residency in 1984 then a Post-doctoral Research Fellowship in Neuroimmunology in 1987, both at the University of Pennsylvania.Dr. Cohen has worked at the Mellen MS Center at the Cleveland Clinic since 1994 and was Director 2014-2017.He currently is Director of the Experimental Therapeutics Program, the Clinical Neuroimmunology Fellowship, and the MS Academic Coordinating Center.Dr. Cohen has published extensively on clinical, immunologic, and imaging aspects of MS.He has had a leadership role in a large number of clinical trials of potential therapies for MS, translational studies, studies to validate outcome measures, and observational studies. He recently served as Chair of the International Advisory Committee on Clinical Trials in MS and Co-Chair of the International Panel on Diagnosis of Multiple Sclerosis which proposed the 2017 McDonald Criteria.He currently is President of ACTRIMS.


Prof. Giancarlo Comi
Institute of Experimental Neurology, IRCCS San Raffaele Hospital and University, Milan

Giancarlo Comi is Professor of Neurology, Chairman of the Department of Neurology, and Director of the Institute of Experimental Neurology at Vita-Salute San Raffaele University, Milan, Italy. He is also President of the European Charcot Foundation (ECF), a member of the Board of Administration of the Italian Multiple Sclerosis Foundation and of the Scientific Committee of Associazione Italiana Sclerosi Multipla, Co-Chair of the Scientific Steering Committee of the Progressive MS Alliance, and a fellow of the European Academy of Neurology (EAN). He has served as a past president of the European Neurology Society, the Italian Society of Clinical Neurophysiology, and the Italian Society of Neurology.

In recent years, Professor Comi has received the ‘Gh. Marinescu’ honorary award from the Romanian Society of Neurology, and has been awarded honorary memberships of the Russian Neurological Academic Society, the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), the European Neurological Society (ENS) and the Sociedad Espanola de Neurologia. He also received the Charcot Award for MS Research from the MS International Federation (MSIF) in 2015. In the past year Professor Comi was awarded the Gold Medal of ‘Benemeranza Civica’ from the City of Milan and has been recently conferred the honor of merit as Official by the President of Italy.

Prof. Comi has authored and co-authored more than 1000 articles in peer-reviewed journals, and edited several books, with an h-index of 100. He has been the invited speaker for more than 450 conferences, both nationally and internationally. He sits on the executive boards of various scientific associations and on the editorial boards of Clinical Investigation, European Journal of Neurology and Multiple Sclerosis. He is also the Associate Editor of the Neurological Sciences.


Prof. Jorge Correale
Raúl Carrea Institute for Neurological Research (FLENI), Buenos Aires

Dr. Jorge Correale graduated with honors from the Faculty of Medicine, University of Buenos Aires, in 1981. Between 1983 and 1988 he completed the residency of Neurology at the Dr. José María Ramos Mejía Hospital, Buenos Aires, and was appointed Chief of Residents. During the year 1989 he collaborated in the Department of Neuropathology, in the same center. Dr. Correale continued his training as a fellow in Neuroimmunology at the Karolinska Institute in Stockholm, Sweden, between 1989 and 1990. In 1990 he moved to the United States, where he completed a second three-year fellowship in Neuroimmunology at the University of Southern California, with support of the National Multiple Sclerosis Society USA. In 1993 he was appointed Assistant Professor of Neurology at the University of Southern California, and in 1995 Assistant Professor of Microbiology and Molecular Immunology. In 1997, Dr. Correale returned to Buenos Aires as Head of Neuroimmunology and Demyelinating Diseases at the Neurological Research Institute Dr. Raúl Carrea, a position he currently holds, where he develops an intense assistance task in the evaluation and follow-up of MS patients. Between 1998 and 2010 he was Associate Professor at the Austral University in Buenos Aires, teaching Clinical Neurophysiology, Physiopathology and Pain Treatment, and Neurology.

The main objective of Dr Correale's work is to elucidate the role of environmental factors that determine the development or progression of Multiple Sclerosis, understanding the immunological mechanisms implicated. Additionally, the working group of Dr. Correale is focused on evaluating the clinical and immunological variations that are unleashed in particular circumstances of patients with multiple sclerosis such as assisted fertilization, pregnancy and puerperium, as well as the role that sex hormones play in each of these situations. Since 2013 Dr Correale is working at the School of Pharmacy and Biochemistry of the University of Buenos Aires in the biology of glial cells, with the aim of developing models that allow a better understanding of the processes involved in demyelination and remyelination. Dr Correale is a member of the editorial board of different journals of Neurology and Immunology, and he participates in the scientific review panels of the Multiple Sclerosis societies of Italy, the United Kingdom, Ireland, the Netherlands, Australia, and France, collaborating nationally in the evaluation of scientific projects of the Agency for Scientific and Technological Promotion and the Secretary of Science and Technology of the University of Buenos Aires.
Currently, Dr. Correale is a member of the Argentine Medical Advisory Council for Multiple Sclerosis, and member of the Medical and Scientific Board of the MSIF. He has been former Vice President and President of the Argentine Neurological Society, between 2008-2012, President of the Latin American Society for the Study and Treatment of Multiple Sclerosis (LACTRIMS) during the period 2014-2016, and member of the Advisory Board of the International Society of Neuroimmunology (ISNI). He is currently Deputy chair of the MSIF and, and member of the International Advisory Committee on Clinical Trials in MS. Dr. Correale is author of 190 articles published in prestigious journals of Neurology and Immunology, 250 abstracts presented at different international forums in Europe, USA and Canada, 47 chapters in books on Neurology, Multiple Sclerosis and Neuroimmunology, and published as an editor or co-editor 7 books related to Neurology, Multiple Sclerosis and Neuroimmunology.

Prof. Edgardo Cristiano
Hospital Italiano de Buenos Aires & Universitary Institute

Edgardo Cristiano is Director of the Buenos Aires MS Center in Buenos Aires, Argentina

He is Assistant Professor of Neurology at the University of Buenos Aires and the University Institute of the Hospital Italiano.
He is Delegate for Latinamerica at the Scientific Committee from the Charcot European Foundation.
Dr Cristiano is interested in both epidemiological and clinical research in MS, and he leads a large MS centre at the Hospital Italiano de Buenos Aires.

Dr Klaus Dornmair
Institute for Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig-Maximilian University

Klaus Dornmair is leader of the research group group "Target antigens of autoreactive T- and B-cells in autoimmune diseases" at the Institute for Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig Maximilians University (LMU) Munich, Germany since 1999. He studied Biochemistry at the University of Tuebingen, Germany, and received his PhD at the Max-Planck-Institute of Biology, Tuebingen. He then went to Stanford University as a Postdoctoral Fellow and thereafter as a group leader to the Max-Planck-Institute for Neurobiology, Department of Neuroimmunology in Martinsried, Germany. His main interests are repertoires and antigens of components of the adaptive immune system in multiple sclerosis and other diseases. To this end, his group is studying antibodies and T cells in brain tissue and cerebrospinal fluid from subjects with multiple sclerosis and controls.


Prof. Gilles Edan
Rennes University Hospital

Gilles Edan is currently professor of clinical neurology and chair of the Department of Neurosciences at the University Hospital of Rennes, France. After completing his MD at the University of Rennes in 1981, he went on to specialize in neurology under the supervision of Pr Olivier Sabouraud , was a research fellow at Guy’s hospital (London) in neuroimmunology with RAC Hughes in 1987, spent a sabbatical period of 6 months at the MS clinic of UBC with Don Paty and Joel Oger in Vancouver in 1996 and set up a MS clinic in Brittany in 1996. Gilles Edan was one of the members of the international panel for the new diagnostic criteria of MS (Mc Donald criteria) in 2001 and 2005. He published more than 200 peer-reviewed original papers on his MS researches in Journals and several chapters in books on these subjects.


Prof. Óscar Fernández
Biomedical Research Institute of Malaga (IBIMA), Regional University Hospital of Malaga

Director of the Institute of Clinical Neurosciences (and founder) at the Regional University Hospital of Malaga since 2003 until the 28th of August 2015.

Senior Investigator of the Biomedical Research Institute of Malaga (IBIMA). Regional University Hospital of Malaga, since September 2015.
Honorary Professor of the Faculty of Medicine of the University of Malaga since 2007.

Prof. Kazuo Fujihara
Fukushima Medical University School of Medicine

Kazuo Fujihara, M.D. is Professor, Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, and Director, Multiple Sclerosis & Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience (STRINS), Koriyama 963-8563, Japan. Dr. Fujihara is a neurologist and has mainly worked in the field of multiple sclerosis (MS), neuromyelitis optica (NMO) and related neuroimmunological disorders. He contributed to the 2010 and 2016-2017 Revisions to McDonald Criteria in the International Panel on Diagnosis of MS, and is a member of the International Panel on NMO Diagnosis. He has also served on the Board of European Charcot Foundation (2013~), the Executive Committee, International Medical and Scientific Board of The Multiple Sclerosis International Federation (2013~) and an External Reviewer of Malaysian Clinical Practice Guidelines (CPG), Management of Multiple Sclerosis. He is an inaugural member and Deputy Secretary of PACTRIMS and a co-convener of “MS and Other Inflammatory Diseases” in the 23rd World Congress of Neurology (2017, Kyoto). He is a member of International Advisory Board of Sri Lankan Journal of Neurology (2012~), an Honorary Corresponding Member of the Indian Academy of Neurology (2015~), and an Honorary Fellow of the Hong Kong Multiple Sclerosis Society (2015~).


Dr Matteo Gastaldi
IRCCS Mondino Foundation

Matteo Gastaldi graduated in Medicine at the University of Pavia in 2010 summa cum laude, and received the specialization in Clinical Neurology at the same university in 2016 summa cum laude. He completed his PhD in Neurosciences at the University of Pavia in 2018, under the co-supervision of Dr Diego Franciotta (Mondino Foundation, Pavia, Italy) and Prof Angela Vincent (Oxford University, Oxford, UK). He is currently working as a clinical scientist at the Mondino Foundation, where he helds a clinical neuroimmunology outpatient service, and supervises scientific projects of the Neuroimmunology Laboratory. During his PhD he spent one year as a fellow at the Nuffield Department of Clinical Neurosciences (NDCN- Neuroimmunology Laboratory) and at the IDIBAPS Neuroimmunology Laboratory (Hospital Clinic, Barcelona, supervised by Prof. Francesc Graus and Prof. Josep Dalmau), where he focused his activities on antibody detection techniques in neuroimmunological disorders.

His current research interests concern antibody mediated disorders of the central and peripheral nervous system, and focusses on:
-Standardization of Neuroimmunology Laboratory diagnostic strategies
-Clinical and immunological profile of patients with autoimmune encephalitis
-Autoantibodies in acquired demyelinating syndromes of both central and peripheral nervous system

Dr Angelo Ghezzi
Multiple Sclerosis Study Centre of St Antonio Abate Hospital, Gallarate

Dr Angelo Ghezzi is chief emeritus of Neurology. He is the responsible of scientific research at Multiple Sclerosis Study Centre of St Antonio Abate Hospital in Gallarate, Italy, the oldest Italian MS center. He is member of the Steering Committee of the International Pediatric MS Study Group, and member of the Italian MS Study Group of the Italian Neurological Society Dr Ghezzi has been an active researcher, serving as an investigator in many international Phase II and III trials. His research has focused on the areas of optic neuritis, MS and pregnancy, MS and sexual disturbances, MS and epilepsy, MS evolution and prognosis, MRI and clinical correlation with MS, and clinical neurophysiology (evoked potentials, pelvic floor neurophysiology); however, he is especially interested in the clinical and therapeutic aspects of pediatric MS (MS onset in childhood-adolescence, immunomodulatory treatment of juvenile-onset MS). Dr Ghezzi is the editor of 10 books on multiple sclerosis, and author or co-author of more than 200 articles published in international journals.

Prof. Jennifer Gommerman
University of Toronto

Jen received her Ph.D. (Immunology) at the University of Toronto in 1998. She went on to do a post-doctoral fellowship at Harvard Medical School studying the complement pathway and then joined Biogen Inc. as a Staff Scientist in 2000. During her tenure at Biogen, she became interested in B cells, Multiple Sclerosis and the TNF superfamily of molecules. After 3 years in Industry, she returned to Academia as an Assistant Professor (Immunology) at the University of Toronto in 2003, and in 2015 was promoted to full Professor. Jen's basic research continues to focus on how members of the TNF superfamily of molecules regulate immunity and autoimmunity. Her team has uncovered a novel gut-brain axis that regulates neuroinflammation. With respect to translational work, Dr. Gommerman has been examining the role of B lymphocytes in Multiple Sclerosis patients, and she is the lead PI on a study examining the effect of global migration on susceptibility to autoimmune disease.


Prof. Hans-Peter Hartung

Professor Hartung received his undergraduate training at the Universities of Düsseldorf, Glasgow, Oxford and London. After graduation magna cum laude as MD in 1980 he served an immunology fellowship at JohannesGutenberg-University of Mainz. He started his career in neurology at the University of Düsseldorf, where he became assistant professor in 1987. He was appointed professor and head of the MS clinical research group and Vice Chair of the Department of Neurology at Julius-Maximilians-University of Würzburg in 1990 and moved in 1997 to Graz, Austria, to become chairman of the University Department of Neurology. He is currently chair of the Department of Neurology at Heinrich Heine University Düsseldorf, a position he has held since 2001, and since 2012 director of the Center for Neurology and Neuropsychiatry. He is also Medical Director of the Department of Conservative Medicine at Düsseldorf University Hospital.

Professor Hartung’s clinical and translational research interests are in the field of basic and clinical neuroimmunology and in particular multiple sclerosis and immune neuropathies, development of new immunological, neuroprotective and neural repair promoting strategies. He has authored or co-authored more than 900 articles in peer-reviewed journals, one hundred book chapters and edited nine books. He is a Highly Cited Researcher 2017 (Web of Science).

He was President of ECTRIMS and has served / serves amongst others on the executive boards of the European Charcot Foundation, the International Society of Neuroimmunology, Peripheral Nerve Society, INC,WHO Working Group on Multiple Sclerosis, GBS CIDP Foundation International, MSIF and the German MS Society and theUS NMS Society and ECTRIMS clinical trials committee. He is member of the executive board of IMSCOGS. He is/ was also member of the Editorial Board of a number of international journals.

Prof. Stephen L. Hauser
UCSF Weill Institute for Neurosciences, University of California, San Francisco

Stephen L. Hauser, M.D. is the Robert A. Fishman Distinguished Professor of Neurology at the University of California, San Francisco. He is Director of the UCSF Weill Institute for Neurosciences, an umbrella organization that links the clinical and basic neurosciences at UCSF to accelerate research against neurologic diseases. A neuroimmunologist, Dr. Hauser’s research has advanced our understanding of the genetic basis, immune mechanisms, and treatment of multiple sclerosis (MS). His work led to the development of B cell therapies for MS patients, representing a powerful new approach for relapsing forms of the disease and the first therapy of proven value for progressive MS.

Dr. Hauser is a member of the National Academy of Medicine and a fellow of the American Academy of Arts and Sciences and the American Academy of Physicians. He is an editor of the medical textbook Harrison’s Principles of Internal Medicine. Previously chairman of the Department of Neurology at UCSF for 25 years, he has also served as President of the American Neurological Association, President of the Medical Staff at UCSF, Chair of the Research Advisory Committee for the Veteran’s Administration, and editor-in-chief of Annals of Neurology. He also served the Obama administration as a member of the Presidential Commission for the Study of Bioethical Issues charged with advising the President on issues that may emerge from advances in biomedicine and related areas of science and technology.
Dr. Hauser has received numerous awards and honors for his work, including the Jacob Javits Neuroscience Investigator Award, the John Dystel Prize and the Charcot Award for Multiple Sclerosis Research, and the 2017 Taubman Prize for Excellence in Translational Medical Research.
Dr. Hauser is a graduate of MIT (Phi Beta Kappa) and Harvard Medical School (Magna Cum Laude). He trained in internal medicine at the New York Hospital–Cornell Medical Center, in neurology at the Massachusetts General Hospital (MGH), and in immunology at Harvard Medical School and the Institute Pasteur in Paris, France, and was a faculty member at Harvard Medical School before moving to UCSF.

Dr Darius Häusler
Medical University of Goettingen

Dr. Häusler studied biology at the Georg August University of Göttingen (Germany) where he received his Diploma followed by his PhD in Molecular Medicine in 2013. In 2014 he joined Prof. Martin S. Weber’s lab at the Institute of Neuropathology, University Medical Center of Göttingen as a Research Fellow. He is focusing on molecular mechanisms underlying the pathogenesis of multiple sclerosis (MS). To decipher these pathomechanisms and to understand how to counteract them therapeutically in the most efficient and specific manner is the declared goal of his research work.


Prof. Romana Höftberger
Institute of Neurology, Medical University Vienna

Romana Hoeftberger, MD, is Associate Professor in Neuropathology and Neuroimmunology work group leader at the Institute of Neurology, Medical University of Vienna. She started her scientific career as research fellow at the Center for Brain Research, Medical University of Vienna under the supervision of Prof. Hans Lassmann and continued with her training for Neuropathology at the Institute of Neurology. Before her appointment as Associate Professor, she was postdoctoral fellow at the University of Barcelona under the supervision of Prof. Josep Dalmau and Prof. Francesc Graus. Professor Hoeftberger´s fields of expertise are autoimmune disorders of the central and peripheral nervous system with a main focus on antibody-associated autoimmune disorders. Her major interests are in the discovery of novel antibodies in patients with anti-neuronal autoimmune encephalitis and the development of antibody-screening techniques. In addition her research focuses on clinico-pathological correlations and to decipher the functional effects of anti-neuronal antibodies on the targeted antigen in human biopsy and autopsy specimens derived from affected patients.


Prof. Reinhard Hohlfeld
Institute for Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig-Maximilian University

Reinhard Hohlfeld is Professor of Neurology and founding Director of the Institute of Clinical Neuroimmunology, Ludwig Maximilians University of Munich, Germany. http://www.klinikum.uni-muenchen.de/Institut-fuer-Klinische-Neuroimmunologie/en/index.html After his retirement from the position as Director of the Institute, he continues to pursue his research into the autoimmune mechanisms and pathogenesis of neuro-immunological diseases, notably multiple sclerosis, myasthenia gravis, and inflammatory myopathies. He also maintains a long-standing interest in the mechanisms and adverse effects of various immunomodulatory therapies. Dr.Hohlfeld is a member of the scientific advisory boards of the German MS Society, International Federation of MS Societies (MSIF), and International Progressive MS Alliance (PMSA); member of numerous editorial boards of scholarly journals; member of the German National Academy of Science (Leopoldina); external scientific member of the Max Planck Society; and Fellow of the European Academy of Neurology.

Prof. Ludwig Kappos
University Hospital Basel

Grown up in Athens, Greece Ludwig Kappos obtained his M.D. and a Diploma in Clinical Psychology from the University of Würzburg, Germany, in 1980, where he went on to specialise in Neurology and Neuroimmunology, and became Deputy Chief, Division of Clinical Neurology, Max Planck Society, Clinical Research Unit for Multiple Sclerosis. In 1990 he was elected Head of the Outpatient Department, Neurology/Neurosurgery and since 2008 Chair of Neurology at the University of Basel, Switzerland. Research interests include immuno-logical and molecular studies in neuroimmunological diseases, methodology and conduct of therapeutic studies mainly in the field of MS, standardisation of clinical assessment, development of biomarkers and use of magnetic resonance tomography in elucidating the pathogenesis of inflammatory CNS disease and as tool in monitoring therapeutic studies. Ludwig Kappos serves as chair or member in several steering committees and advisory boards of Clinical Trials and Organizations active in the field of MS and general Neurology. Ludwig Kappos has published more than 750 original papers, reviews and book chapters. He has been awarded with several prizes and honorary doctorates for his scientific contributions.


Prof. Luisa Klotz
University Hospital Munster

Professor Luisa Klotz studied medicine at the University of Bonn (Germany), graduating in 2002. She has been a research fellow at the Institute of Molecular Medicine and Experimental Immunology, University of Bonn, where she was a junior group leader within the BONFOR programme. Since 2011 she is an independent group leader for Immunemodulation and since 2013 head of the clinical trial unit ‘Neuroimmunology and IITs’ at the Department of Neurology, University Hospital Münster (Germany) and holds a Professorship for ‘Neurological Immune Therapy’ since 2016.

Her research focusses on immunemodulatory properties of nuclear receptors, innate and adaptive immune responses in CNS autoimmunity, spontaneous EAE models as well as pathologic immune responses in multiple sclerosis and novel therapeutic approaches.
Professor Klotz is CEO of the “Innovative Medical Research” funding organization, Faculty of Medicine, University Hospital Münster and is Co-PI of the Clinical Competence Network Multiple Sclerosis supported by the Federal Ministry of Research and Education (BMBF). Her achievements have been recognized by several awards, among them the Sobek award 2012 of the German Society for Multiple Sclerosis (DMSG).
Prof. Hans Lassmann
Center for Brain Research, Medical University of Vienna

Hans Lassmann is retired Professor for Neuroimmunology at the Center for Brain Research at the Medical University of Vienna, Austria. He studied medicine at the University of Vienna and was then trained in clinical and experimental neuropathology at the Institute of Neurology. This scientific education was complemented by a post-doctoral training in experimental neuropathology and neuroimmunology at the New York State Institute for Basic Research in Developmental Disabilities. He then became the head of a research Unit at the Austrian Academy of Sciences and Professor for Experimental Neuropathology in the University of Vienna. In 1999 he was appointed as full professor for Neuroimmunology at the Medical University of Vienna and as the founding director of the Center for Brain Research. He retired from this position in 2017 and is currently engaged as a research associate in the Department of Neuroimmunology. His major research interests are in the field of neuroimmunology and immunopathology of the central nervous system with special focus on the pathogenesis of inflammatory brain diseases, including multiple sclerosis. He combines basic research in experimental disease models with translational research in humans. He has received numerous research wards, including the Charcot award, the research prize of the Sobek foundation and the Zülch Award of the Reemtsma Stiftung. He is honorary member of the Japanese and the French Neurological Societies and Member of the Austrian and the German (Leopoldina) Academies of Sciences.


Prof. Letizia Leocani
Institute of Experimental Neurology, IRCCS San Raffaele Hospital, Milan

Letizia Leocani is Associate Professor of Neurology at San Raffaele University and Supervisor of the Experimental Neurophysiology Unit and of Magnetic IntraCerebral Stimulation center. She had a PhD in Human Physiology and she has been Research Fellow at the Human Motor Control Section of the National Institutes of Health in Bethesda-USA. Her fields of interest involve translational validation of electrophysiological and OCT markers of neurological diseases and of treatment using non invasive brain stimulation.

Dr Roberta Magliozzi
University of Verona

Dr. Roberta Magliozzi, PhD, is a researcher of the Neuroscience Department of University of Verona. Since 2003 her main interest was the study of chronic inflammatory response and the role of ectopic lymphoid-like structures in the meningeal compartment of experimental MS animal models and in post-mortem brain samples. Dr. Magliozzi has focused her study in cell and molecular mechanisms involved in cortical grey matter damage and the correlation with intrathecal inflammation in MS, this with the main aim to identify possible neuroimmunological mechanisms involved in multiple sclerosis and potential new biomarkers of MS progression.

Dr Romina Mariano
West Wing John Radcliffe Hospital Oxford University Hospitals Trust, Department of Neurology

Dr Romina Mariano graduated (with distinction) from the University of the Witwatersrand Medical School, Johannesburg, South Africa in 2012. In 2011 she completed an Advanced Neurology Clerkship at Harvard Medical School (with distinction). From 2013 to 2016 she completed her foundational and core medical training at Charlotte Maxeke Johannesburg Academic Hospital. During this time she also taught and mentored medical students.

Romina is currently reading for a DPhil (PhD) at the Nuffield Department of Clinical Neurosciences, University of Oxford. She was awarded a Rhodes Scholarship in 2016 as well as an Oppenheimer Memorial Trust Scholarship and Goodger & Schorstein Scholarship in 2019. She is an Honorary Clinical Fellow in the Department of Neurology at the John Radcliffe Hospital. Her research focuses on structural, quantitative and functional MRI for the study of demyelinating diseases in the spinal cord.
She is actively involved in teaching within Oxford University and within the wider community through programs that teach neuroscience in public schools in underserved areas. She enjoys contributing to public engagement activities and has continued her mentorship through programs that support high school students from low income backgrounds with an interest in STEM careers. She is a co-leader of the International Women in MS (iWiMS) Scientific Group on NMOSD and MOG-Ab-associated Disorders and a Scholar Programme Facilitator for the Rhodes Trust.  

Prof. Edgar Meinl
Institute for Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig-Maximilian University

Edgar Meinl is Professor at the Institute of Clinical Neuroimmunology, LMU Munich. He studied medicine in Gießen, Germany and performed his MD thesis with Prof. Hartmut Wekerle at the Clinical Research Unit for Multiple Sclerosis of the Max Planck Society in Würzburg. He was a PostDoc at the Max Planck Institute of Psychiatry in Martinsried, working on MBP-specific T cells in MS. Thereafter he was a group leader at the Institute of Clinical and Molecular Virology, University Erlangen-Nürnberg. In 1999, he joined the Institute of Clinical Neuroimmunology, LMU Munich. Research interests: The BAFF-APRIL system as part of the B cell fostering environment in the inflamed CNS in MS; Details of antigen-recognition and pathogenicity of MOG-Abs; Mechanisms of immunomodulatory treatments in MS. Editorial activities: PLOS One (Academic Editor), Journal of Biological Chemistry (Reviewing Editor), Frontiers in Neurology and Frontiers in Immunology (Associate Editor).


Dr Laure Michel
Rennes University Hospital, Pontchaillou Hospital

Dr. Laure Michel, MD, PhD is a neurologist at University Hospital, Rennes, FRANCE. She earned her medical degree, residency in neurology, and international PhD in Immunology at University of Nantes, France. From 2013 to 2016 she joined Pr Alexandre Prat’s lab (Research Center of Montreal, Québec, Canada) as a Research Fellow and she worked on mechanisms of B cells migration inside the CNS in multiple sclerosis. Her research interests include B cell differentiation and B/T collaboration in MS.


Prof. Tatsuro Misu
Tohoku University Graduate School of Medicine

Dr. Tatsuro Misu is presently the Lecturer at the Department of Neurology, Tohoku University Hospital, Sendai, Japan, and leads the MS Research Group in Tohoku University. After he graduated from the Faculty of Medicine, HirosakiUniversity with MD in 1997, he pursued clinical and post-graduate training at the Department of Neurology in TohokuUniversityHospital and obtained his PhD from TohokuUniversity in 2003. Since 2005, he is an Assistant Professor at Tohoku University. In 2010, he stayed in Vienna as a Gastforscher in the department of Neuroimmunology at Vienna Medical University (Prof. Lassmann). His principal research activity has been in neuroimmunology and neuropathology, especially in clinical and pathological analysis of neuromyelitis optica (NMO) and multiple sclerosis (MS), and clinical management of such disease patients.

Especially, his life work in NMO has started from the clinical research of pure optic-spinal MS in Japan, published in Brain 2002, confirming the existence of patients selectively manifesting optic neuritis and myelitis. He found the predominance of intractable hiccup and nausea in NMO, which has been associated with specific anatomical site, “area postrema”, published in Neurology 2005, which is now including in Wingerchuk’s NMO criteria 2015, as a main sign of NMO. In neuropathology, he initially revealed the specific NMO lesion as the loss of aquaporin 4 and GFAP but the relative preservation of MBP, suggesting the disease concept primary “astrocytopathy”, published in the Tohoku Journal of Experimental Medicine 2006 and Brain 2007.
He has published about a hundred papers on well-known peer-reviewed international journals including many top-journals in this field. He was awarded as the best presenter from Japanese Society of Neuroimmunology (2007), Pan-Asian committee of treatment and research in MS (PACTRIMS) (2008), and ECTRIMS (2013).

Prof. Lucia Moiola
Institute of Experimental Neurology, IRCCS San Raffaele Hospital, Milan

Dr. Lucia Moiola is a Neurologist of the Department of Neurology at Ospedale San Raffaele, Milan, Italy since 1999. She is the Coordinator of the Multiple sclerosis Centre of the IRCCS Ospedale San Raffaele, Milan, Italy since 2011. Since 2009 is tenured professor for the Specialization School in Neurology, Università Vita-Salute San Raffele, Milan.

Dr. Lucia Moiola is an expert within Multiple Sclerosis and is involved in MS research projects, MS Clinical trials, including postmarketing observational phase IV trials such as those on paediatric MS. Since the last two years she is involved in study of infections in patients treated with DMDs and their prevention. Furthermore, she is an expert within CNS inflammatory diseases particularly primary CNS vasculitis and secondary CNS vasculititis, especially Neurolupus regarding the latter.
Dr. Moiola has authored and co-authored more than 150 articles in peer-reviewed journals with an h-index of 34. She has been invited speaker for numerous scientific conferences and in many advisory scientific board, both nationally and internationally and is part of the reviewer board for Neurological Sciences, Multiple Sclerosis journal, BMC Journal, Neurology and Therapy.

Prof. Xavier Montalban
Multiple Sclerosis Centre of Catalonia, University of Toronto and BARLO MS Centre St Michaels Hospital

Dr. Montalban is the Director of the Division of Neurology at the University of Toronto and Director of the MS centre at St Michael’s Hospital in Toronto. Also, he currently Chairs the Department of Neurology-Neuroimmunology and is the director of the Multiple Sclerosis Centre of Catalonia at the Vall d’Hebron University Hospital in Barcelona. He is the former director of the Department of Neuroscience and Chief of the Neuroimmunology Research Group at the Vall d’Hebron Research Institute. Dr. Montalban received his medical license, trained as a Neurology specialist and completed his PhD in neuroimmunology during the 1980s at the Universitat Autònoma de Barcelona. He went on to undertake a postdoctoral fellowship at the Lupus Research Institute, Guy’s & St. Thomas’ Hospital plus additional clinical training at the National Hospital for Neurology and Neurosurgery, Queen Square in London, United Kingdom.

Dr. Montalban is Vice-President of Fundació Esclerosi Múltiple (MS Foundation), President of the Fundació Cemcat and former President of the Executive Committee of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS). He is a member of the US National Multiple Sclerosis Society Clinical Trials Committee and he chairs the Medical & Scientific Board of the Multiple Sclerosis International Federation (MSIF). He is a member of the Board of the European Charcot Foundation.

In the past twenty years, Dr. Montalban has been in the inception phases and on steering committees of many clinical trials related to multiple sclerosis. He has authored over 600 original and revision publications in international peer-reviewed journals, as well as several book chapters. Recently, he co-directed the development of the first ECTRIMS-EAN Multiple Sclerosis Treatment Guidelines. He is the editor of the Clinical Cases Section of the Multiple Sclerosis Journal.

His research interests include clinical trials, clinical aspects of MS, MR imaging and biological prognostic factors of disease evolution and treatment response, immunological mechanisms of the disease and other aspects of clinical management of MS.

Prof. Alexandre Prat
University of Montreal

Dr Prat obtained his undergraduate degree (B.Sc.) in biochemistry from Université de Montréal in 1990 and an MD-MSc in 1995. Dr Prat completed his Neurology residency training at McGill University (Montreal Neurological Institute) in 2003, after having completed a Ph.D. degree (2000) in the laboratory of Dr Jack P. Antel. His PhD work focused on the development of the human Blood-Brain Barrier. Dr Prat is an active member of the Royal College of Physician and Surgeons of Canada (Neurology) since 2003. In 2000, he received the prestigious S. Weir Mitchell Award of the American Academy of Neurology. Dr Prat is a staff neurologist at the CHUM (Montréal) and is Full Professor of Neurosciences (with Tenure) at Université de Montréal. Dr Prat held the Donald Paty Research Chair of the Multiple Sclerosis Society of Canada and was a senior Scholar of the FRQ-S (2012-2016). He now holds the Senior Canada Research Chair en Multiple Sclerosis and was inducted at the College of researcher of the Royal Society of Canada in 2015.

From 2015 until 2018, he was Deputy Director for Development at the CHUM Research Center, a research institution with over 120 investigators and 2000 employees. In 2015, he was elected at the Royal Society of Canada. The current research interests of the Prat lab include the immunological roles of the BBB, the mechanisms of monocytes and lymphocyte migration across the BBB and the physiological regulation of the Blood-Brain Barrier functions by glial cells. The underlying hypothesis of Dr Prat’s work is that deciphering the mechanisms by which the Blood-Brain Barrier controls the passage of cells and molecules to the CNS should lead to the understanding of diseases such as MS and brain tumors, as well as to the discovery of novel routes for delivery of drugs and chemotherapies into the CNS. The research activities of the Prat lab include a special emphasis towards the biology of human and mouse TH1 and TH17 lymphocytes, as well as the important role of B lymphocytes in MS. The lab routinely performs 16 color flow cytometry analysis of human or mouse CNS and peripheral blood cells, multiphoton dynamic imaging of CNS vessels, confocal microscopy of human MS brain samples, active adoptive transfer and spontaneaous/transgenic EAE, as well as primary cell culture of human or mouse CNS endothelial and glial cells.
Currently, the research team of Dr Prat is composed of 3 post-doctoral fellows, 6 Ph.D. students, 4 M.Sc. students and 3 technicians. Most of the students and post-docs in the Prat lab hold prestigious National or International studentship or fellowships. The lab is supported by 3 operating grants from the CIHR, one Progressive MS Alliance international team grant, 2 operating grants from the MS Society of Canada and one large operating pan-canadian Team grant from the MS Research Foundation of Canada. Dr Prat has published more than 100 peer-reviewed research articles in international journals such as Science, Cell, Nature Medicine, Nature Immunology, Science Translational Medicine, PNAS, The Journal of Neuroscience, The Journal of Immunology, Annals of Neurology, PLOSone and Brain.

Dr Mara Rocca
Institute of Experimental Neurology, IRCCS San Raffaele Hospital, Milan

Dr. Rocca is currently Head of the “Neuroimaging of CNS White Matter Unit”, Department of Neurology, Institute of Experimental Neurology, Scientific Institute Ospedale San Raffaele, Milan, Italy.

Her activity is mainly focused on the application of structural and functional MR based techniques to improve the understanding of central nervous system function and dysfunction in healthy individuals and diseased people, particularly patients with multiple sclerosis (MS) and other white matter disorders.
Dr. Rocca is currently conducting and coordinating several national and international projects in adult and pediatric populations. She is also extensively applying advanced methods of analysis in an attempt to improve the understanding of the role of brain functional and structural plasticity in the different phases of MS, and the influence of pharmacological and rehabilitative interventions on brain reorganization.
She is member of various national and international Scientific Societies and, in some of them, she covered or is covering institutional roles (MAGNIMS, Neuroimaging Study Group of the Italian Neurological Society, AMPC of the ISMRM, International Pediatric Multiple Sclerosis Study Group, European Academy of Neurology). She coordinated the MRI acquisition and analysis of several large-scale international MRI-monitored trials of MS. From 2018, she is chair of the MAGNIMS network.
Dr. Rocca is author or co-author of more than 430 papers published on peer-reviewed journals and of 52 book chapters. She is also reviewer of several international scientific journals and for many Governmental Organizations and private Foundations. Due to her scientific activity she participated, as a speaker and/or chairman, to more than 370 international congresses and she received several national and international Awards. In 2013, Dr. Rocca was awarded the “Rita Levi Montalcini” Prize for her outstanding contributions to the study of MS.
Dr. Rocca is Non-Tenured Professor at Università Vita-Salute San Raffaele, Milan. In 2017, she received the qualification as Full Professor of Neurology in Italy.

Prof. Krzysztof Selmaj
Neuroimmunology Laboratory, Medical University Lodz

Dr. Selmaj is the Professor of Neurology at the Medical University of Lodz (MUL) and a Visiting Associate Professor at Albert Einstein College of Medicine, New York. He is a Chairman at the Department of Neurology and Director of the Neuroimmunology Laboratory at the MUL. Dr. Selmaj received training in neurology and neuroimmunology at the Charing Cross and Westminster Medical School, University of London, and at Albert Einstein College of Medicine, New York. Dr. Selmaj has been elected to serve as a Vice-President of the European Federation of Neurological Societies (EFNS) in 1999-2005 and a member of several other international advisory boards. He wasa President of the Polish Neurological Society. He served as a member of the editorial boards for European Journal of Neurology,Journal of Neuroimmunology, and Polish Neurology and Neurosurgery.His research activity considers investigations in neurobiology and neuroimmunology with a particular interest in mechanisms of demyelination and multiple sclerosis. He published over 150 papers in the field of neurology and immunology.


Prof. Per Soelberg Sorensen
Danish MS Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet

Per Soelberg Sorensen is Professor of Neurology at the University of Copenhagen and senior consultant at Department of Neurology, Rigshospitalet, Copenhagen. He is the founder of the Danish Multiple Sclerosis Center. Core elements in his research include development of new MS therapies, translational and biomarker research, and he has initiated and conducted several large international trials. He has authored more than 400 scientific publications, 353 of which are indexed in PubMed. Professor Sorensen was Founding Editor‐in‐chief of the European Journal of Neurology from 1994 to 2003 and is currently member of the editorial board of Multiple Sclerosis Journal, European Journal of Neurology, Therapeutic Advances in Neurological Disorders, and Multiple Sclerosis and Demyelinating Disorders.
Professor Sorensen is Secretary General of the European Committee for Treatment and Research in Multiple sclerosis (ECTRIMS); Executive Board member of the European Academy of Neurology; Executive Board member of the European Charcot Foundation for Research in Multiple Sclerosis; Member of the Medical Advisory Board of the International Federation of Multiple Sclerosis Societies (IFMSS); Member of the International Advisory Committee on Clinical Trials in MS, under the sponsorship of the US National MS Society and ECTRIMS; and Chairman of the Danish Multiple Sclerosis Group.


Prof. Antonio Uccelli
University of Genua, IRCCS Azienda Ospedaliera Universitaria San Martino

Antonio Uccelli was born in Genoa (Italy) in 1964 where he obtained his medical doctoral degree in 1987. He completed his residency of neurology at the University of Genoa in 1993. In 1992 he attended, as post-doctoral fellow, the Laboratory of Neuroimmunology - Department of Neurology - University of California San Francisco (UCSF) directed by Professor S.L. Hauser. From 1993 to 2011 he had a faculty position in the Department of Neurology of the University of Genoa. From December 2011 to June 2017 he was Associate Professor of Neurology of the University of Genoa, then since June 2017 he is Full professor. Since 2018 he is Scientific Director of IRCCS Policlinco San Martino. From 2014 to 2019 he was Director of Centre of Excellence for Biomedical Research (CEBR). Since 2009 he is the Director of the Center for Research and Cure of Multiple Sclerosis of the University of Genoa. Since 1995 he is the Director of the Neuroimmunology Unit of the Department of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI) of the IRCCS Azienda Ospedaliera Universitaria San Martino – IST Istituto Nazionale per la Ricerca sul Cancro focusing his research activities on multiple sclerosis and more recently on adult stem cells. From 2012 to 2015 he was the Coordinator of the Residency School of Neurosurgery of the University of Genoa. Since 2016 he is Coordinator of Curriculum “Neuroscienze cliniche e sperimentali” – in the PhD program on Applied Neurosciences. Prof. Uccelli is co-author of 185 peer-reviewed scientific publications with a Total impact factor: 1.405 - mean IF/publication: 7,6. Dr Uccelli’s C.I. (Citation Index Scopus) is 12.253 (Citation Index including publication where AU is part of research groups) is 12.325 - H Index is 49. Prof. Antonio Uccelli is in Top Italian Scientists list (http://www.topitalianscientists.org). In 2001 he received the Rita Levi Montalcini Award, yearly assigned to the best Italian researcher in the field of MS. In 2009 received the Melvin Jones Fellow Award (for dedicated humanitarian services Lions Clubs International Foundation) and in 2013 the Royan International Research Award - an annual prize awarded to the excellences in Reproductive Biomedicine, Reproductive Health, and Stem Cell Biology and Technology. He has been invited to give seminar and keynote lectures at many Academic sites and conferences all over the world. Since 1995 he has been involved as Co-Investigator or Principal Investigator in international and national clinical trials, following GCP guidelines. Last GCP training:16 Mar 2016. I hereby grant my permission for my personal data to be used pursuant to the Italian law 196/2003, regarding the privacy of individuals.

Prof. Patrick Vermersch
Lille University Hospital

Patrick Vermersch studied medicine at the University Hospital in Lille, where he graduated in neurology. He then completed his education in more basic research fields, mainly in cellular biology between 1990 and 1994 with a PhD focused on biochemical abnormalities associated with Alzheimer’s and other neurodegenerative diseases. He has also conducted research related to the characterisations of post-transcriptional anomalies of Tau proteins. His research interests then turned to multiple sclerosis (MS). Prof. Vermersch is head of one of the departments of neurology at the University of Lille, which deals with MS and other neuroinflammatory diseases. The department’s principal scientic interests are neuroimmunology and markers of disease evolution. Prof. Vermersch is currently vice-president for research in biology and health at the University of Lille. In the year 2000, he created with colleagues the first MS network in northern France to improve both care and research into MS. His current areas of interest are prognostic markers of MS and neuroimmunology in general. He participates in many therapeutic protocols on MS. He has published approximately 390 scientific papers as author or co-author. His Hi is 60.


Prof. Howard Weiner

Howard L. Weiner is the Robert L. Kroc Professor of Neurology at the Harvard Medical School, Director and Founder of the Partners MS Center and Co-Director of the Ann Romney Center for Neurologic Diseases at Brigham & Women's Hospital in Boston. He has pioneered immunotherapy in MS and has investigated immune mechanisms in nervous system diseases including MS, Alzheimer’s Disease, ALS, stroke and brain tumors. He has also pioneered the investigation of the mucosal immune system for the treatment of autoimmune and other diseases and the use of anti-CD3 to induce regulatory T cells for the treatment of these diseases. He is the author of the book CURING MS and the award winning film documentary WHAT IS LIFE? THE MOVIE. In 2004, Harvard Medical School honored him with the establishment of the Howard L. Weiner Professorship of Neurologic Diseases. Dr. Weiner is the 2007 recipient of the John Dystel Prize for MS Research and in 2012 he received the NIH Director’s Transformative Research Award for investigating the innate immune system in Alzheimer’s disease. He completed his second film, a feature length drama entitled ABE AND PHIL’S LAST POKER GAME which he wrote and directed and which stars Martin Landau and Paul Sorvino.